Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|June 16, 2005
mTOR--beyond transplantationDeborah A Young, Cheryl L Nickerson-Nutter
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritisMartin Hegen, Matthias Gaestel, Cheryl L Nickerson-Nutter, et al.
Cellular Immunology|September 21, 2010
The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 miceHeather MacLeod, Debra G Goodwin, Christy Damphousse, et al.
The Journal of Experimental Medicine|May 14, 2003
Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritisMartin Hegen, Linhong Sun, Naonori Uozumi, et al.
Neuropharmacology|December 15, 2010
The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluidCheryl L Nickerson-Nutter, Debra Goodwin, Marina W H Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2014
Modeling the clinical phenotype of BTK inhibition in the mature murine immune systemMicah J Benson, Varenka Rodriguez, David von Schack, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2011
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritisKyung-Hee Kim, Andreas Maderna, Mark E Schnute, et al.
Bioorganic & Medicinal Chemistry|November 14, 2007
Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2alpha: optimization of in vitro potency and rat pharmacokinetics for oral efficacyKatherine L Lee, Mark L Behnke, Megan A Foley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2013
Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritisAndrew L Rankin, Nilufer Seth, Sean Keegan, et al.
Pageof 2